الرسائل الموجهة للمختصين الصحيين
الرسائل الموجهة للمختصين الصحيين
| المنتج | التاريخ | معلومات السلامة | المرفقات |
|---|---|---|---|
| Cilest® - Ethinylestradiol, Norgestimate | 2013-07-08 | The reason for the recall is that dissolution testing of norgestimate.
|
|
| TYKERB® - Lapatinib | 2013-06-26 | Comparative data have shown that Lapatinib based regimens are less effective than trastuzumab based regimens in certain settings.
|
|
| Plavix® - Clopidogrel | 2013-06-19 | Regarding Bleeding Risk with Plavix in Atrial Fibrillation Patients.
|
|
| Curacne® - Isotretinoin | 2013-06-10 | Pregnancy Prevention Program
|
|
| ROACCUTANE®- Isotretinoin | 2013-06-09 | Pregnancy Prevention Program
|
|
| Tysabri® - Connect | 2013-05-29 | Risk of progressive multifocal leukoencephalopathy PML |
|
| Protelos® - Strontium ranelate | 2013-05-27 | Increased risk of myocardial infarction |
|
| Miacalcic® - Calcitonin | 2013-05-11 | increased risk of malignancies with long term calcitonin use |
|
| Solpadeine® - Paracetamol, Caffeine, Codeine Phosphate | 2013-05-07 | The use of codeine containing products for children after tonsillectomy and /or adenoidectomy surgery |
|
| Vastarel® - Trimetazidine | 2013-05-01 | Outcome of the Benefit-Risk Re-evaluation of Trimetazidine |
|